Antares Pharma Inc. (NASDAQ:ATRS) announced Thursday that the U.S. Food and Drug ... Antares submitted the Xyosted application in December 2016. Antares stock was up 60% this year, based on today's closing price, with the …
For more information, get Portfolio Grader’s complete analysis of ONDK stock. Hi-Crush Partners ... Article printed from InvestorPlace Media, http://investorplace.com/2016/06/5-stocks-with-ugly-earnings-revisions-phh-atrs-ondk-hclp …
A year ago, they were trading at $1.53. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRS at https://www.zacks.com/ap/ATRS
A stock moving multiple “ATRs” in the same direction indicates a quantifiable measurement, especially when we …
If you want a Stock Review on BAX, ATRS, IART, or BDX then come over to http://dailystocktracker.com/register/ and …
KFVS121mon
SAN DIEGO & EWING, N.J.--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP announces that a …
If you want a Stock Review on BAX, ATRS, IART, or BDX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Research coverage has been initiated by DailyStockTracker.com on Baxter …
Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …